BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//YourOrganization//EventDownload//DE
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:69dd5beb2361c@www.leap-up.com
DTSTAMP:20260413T231107Z
DTSTART:20200415T160000Z
DTEND:20200415T170000Z
SUMMARY:Online-Seminar "COVID-19 Impact on Clinical Trials and U.S. Regulatory Approval"
DESCRIPTION:Learn from German Accelerator&rsquo\;s experienced regulatory mentor\, Greg Dombal\, how to navigate the impact of COVID-19 on clinical trials and FDA approval timelines and processes. The German Accelerator team will provide answers on how startups can mitigate their risks around trial integrity\, safety of trial participants\, and other relevant issues. During the session\, opportunities for startups will be highlighted\, such as the FDA&rsquo\;s recently announced special emergency program for possible therapies\, the Coronavirus Treatment Accelerator Program (CTAP). This online seminar will be moderated by Marc Filerman\, CEO German Accelerator Life Sciences.&nbsp\;
END:VEVENT
END:VCALENDAR